ProCE Banner Activity

A New Look at ART Switch Therapy: Western European Perspectives From IAS 2021

Clinical Thought
Here’s why I think we can be reassured by the multinational SALSA study findings, which demonstrated noninferior virologic efficacy of switching vs continuing various 3-drug or 4-drug regimens.

Released: August 23, 2021

Expiration: August 22, 2022

Share

Faculty

Josep M. Llibre

Josep M. Llibre, MD, PhD

Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.

ViiV Healthcare

Partners

IAS 2021

ProCE Banner

Faculty Disclosure

Primary Author

Josep M. Llibre, MD, PhD

Senior Consultant
Infectious Diseases Division
Fight Infections Foundation
University Hospital Germans Trias
Badalona, Barcelona, Spain

Josep M. Llibre, MD, PhD, has disclosed that he has received funds for research support from Gilead Sciences; consulting fees from Gilead Sciences, Janssen Cilag, and ViiV Healtchare; and fees for non-CME/CE services from Gilead Sciences, Thera Technologies, and ViiV Healthcare.